Related Experiment Video
Updated: Jul 16, 2026

Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
Published on: August 26, 2014
Endoscopic diagnosis of refractory ulcerative colitis
Refractory ulcerative colitis (UC) lesions often appear in the proximal colon and may indicate poor treatment response. Endoscopic diagnosis is crucial for guiding effective UC patient management.
Area of Science:
- Gastroenterology
- Internal Medicine
- Colorectal Surgery
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease.
- Refractory UC presents a significant clinical challenge, often defined by resistance to systemic steroids.
- Understanding the endoscopic features of refractory UC is essential for optimizing patient care.
Purpose of the Study:
- To elucidate the endoscopic characteristics and clinical presentation of refractory ulcerative colitis (UC).
- To determine the frequency and anatomical location of refractory lesions in severe UC patients.
- To compare endoscopic findings, lesion locations, treatment efficacy, and CMV infection rates between steroid-resistant (SH-resistant) and steroid-responsive (SH-responsive) UC.
Main Methods:
- A cohort of 68 severe UC patients was analyzed.
- Patients were categorized into SH-resistant UC (n=41) and SH-responsive UC (n=27).
- Comparison focused on endoscopic findings, lesion locations, treatment outcomes, and CMV co-infection.
Main Results:
- SH-resistant UC frequently exhibited longitudinal ulcers and extensive mucosal abrasion.
- Refractory lesions were significantly more common in the proximal colon of SH-resistant UC patients.
- Patients with refractory lesions showed a higher likelihood of ineffective treatment; however, LCAP treatment yielded better remission rates (10/14) compared to steroids alone (12/30).
- A subset of steroid-refractory UC patients with detected CMV also demonstrated resistance to steroids.
Conclusions:
- Endoscopic assessment is critical for accurate diagnosis and guiding therapeutic decisions in UC.
- Identifying refractory lesions aids in predicting treatment response and may inform the selection of advanced therapies like LCAP.
- Further investigation into the role of CMV co-infection in steroid resistance is warranted.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Inflammatory Bowel Disease II: Ulcerative Colitis
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
Endoscopic Procedures II: Colonoscopy
